[Other] One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes

 Close Closed
kumark17 Post time 2024-5-23 14:37:51 | Show all posts |Read mode
Reward20points

journal:EuroIntervention

Authors:Davide Cao; Pascal Vranckx; Marco Valgimigli; Samantha Sartori; Dominick  J. Angiolillo; Sripal Bangalore; Deepak  L. Bhatt; Yihan Feng; Junbo Ge; James Hermiller; Raj  R. Makkar; Franz-Josef Neumann; Shigeru Saito; Hector Picon; Ralph Toelg; Aziz Maksoud; Bassem  M. Chehab; James  W. Choi; Gianluca Campo; José  M. De la Torre Hernandez; Mitchell  W. Krucoff; Vijay Kunadian; Gennaro Sardella; Alessandro Spirito; Holger Thiele; Olivier Varenne; Birgit Vogel; Yujie Zhou; Stephan Windecker; Roxana Mehran

Published date:--

DOI:10.4244/eij-d-23-00658

Article link:http://dx.doi.org/10.4244/eij-d-23-00658

Article Source:Europa Digital & Publishing


Remark:
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Senior Member
  • post

  • reply

  • points

    710

Latest Reply

Return to the list